Catalyst Sues FDA Over $375,000 Rare Disease Treatment

Drug Industry Daily
A A
A Florida drug company at the heart of ongoing disputes over the price of life-saving drugs has doubled down, bringing a federal lawsuit against the FDA for the agency’s alleged end-run around the drug company’s commercial rights.

To View This Article:

Login

Subscribe To Drug Industry Daily